Key points are not available for this paper at this time.
Design
Review
Answers are grounded in this paper and cite their sources.
Highlights tetherin as potential antiviral target; leaves open clinical translation and human pathogenicity effects.
Tetherin (BST2/CD317) has been recently recognized as a potent interferon-induced antiviral molecule that inhibits the release of diverse mammalian enveloped virus particles from infected cells. By targeting an immutable structure common to all these viruses, the virion membrane, evasion of this antiviral mechanism has necessitated the development of specific countermeasures that directly inhibit tetherin activity. Here we review our current understanding of the molecular basis of tetherin's mode of action, the viral countermeasures that antagonize it, and how virus/tetherin interactions may affect viral transmission and pathogenicity.
No takes yet. Share an insight, caveat, or question.
Tortorec et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: